Literature DB >> 16365177

When does the presence of the target predict response to the targeted agent?

Emily K Bergsland.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16365177     DOI: 10.1200/JCO.2005.03.6913

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

Review 2.  [Future of chemotherapy].

Authors:  M-O Grimm; F H Hartmann; R Ackermann
Journal:  Urologe A       Date:  2006-05       Impact factor: 0.639

Review 3.  Prognostic factors for anaplastic astrocytomas.

Authors:  Alessia Compostella; Alicia Tosoni; Valeria Blatt; Enrico Franceschi; Alba A Brandes
Journal:  J Neurooncol       Date:  2006-09-26       Impact factor: 4.130

4.  [Molecular heterogeneity of malignant melanomas].

Authors:  K Glatz
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

Review 5.  Targeted therapy for advanced renal cell carcinoma.

Authors:  C Coppin; L Le; F Porzsolt; T Wilt
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

6.  Targeted therapy for metastatic renal cell carcinoma.

Authors:  Fabian Hofmann; Eu Chang Hwang; Thomas Bl Lam; Axel Bex; Yuhong Yuan; Lorenzo So Marconi; Börje Ljungberg
Journal:  Cochrane Database Syst Rev       Date:  2020-10-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.